US Patent Issued to KEZAR LIFE SCIENCES on April 14 for "Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,711, issued on April 14, was assigned to KEZAR LIFE SCIENCES INC. (South San Francisco, Calif.).

"Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors" was invented by Henry Johnson (San Bruno, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are triazacyclododecansulfonamide ("TCD")-based protein secretion inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same. For example, provided herein are compounds of Formula (I) and pharmaceutically acceptable salts and compositions including the same. The compounds disclosed herein may...